Celsion Corp is a fully-integrated oncology drug development company. The Company is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.
$2.04
As of 03/03/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.